865203-79-8

Basic information

• Product Name: 2-(4-ETHYLPIPERAZIN-1-YL)BENZALDEHYDE
• Synonyms: 2-(4-ETHYLPIPERAZIN-1-YL)BENZALDEHYDE
• CAS NO: 865203-79-8
• Molecular Formula: C₁₃H₁₈N₂O
• Molecular Weight: 218.29
• Mol File: 865203-79-8.mol

Chemical Properties

• Boiling Point: 346.4°C at 760 mmHg
• Flash Point: 146.4°C
• Appearance: /
• Density: 1.08g/cm³
• Vapor Pressure: 5.78E-05mmHg at 25°C
• Refractive Index: 1.568
• CAS DataBase Reference: 2-(4-ETHYLPIPERAZIN-1-YL)BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-ETHYLPIPERAZIN-1-YL)BENZALDEHYDE(865203-79-8)
• EPA Substance Registry System: 2-(4-ETHYLPIPERAZIN-1-YL)BENZALDEHYDE(865203-79-8)

Safety Data

• Hazard Codes: Xi
• Statements: 36
• Safety Statements: 26
• Hazardous Substances Data: 865203-79-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-(4-ETHYLPIPERAZIN-1-YL)BENZALDEHYDE is used as a potential ligand for various receptors and enzymes due to its unique chemical structure and the presence of the 4-ethylpiperazine group, which may contribute to its interactions with biological targets.
Used in Medicinal Chemistry and Drug Design:
2-(4-ETHYLPIPERAZIN-1-YL)BENZALDEHYDE is used as a compound of interest in the development of new drugs and therapeutic agents, given its potential pharmacological applications and its effects on the central nervous system.
Used in Research and Development:
2-(4-ETHYLPIPERAZIN-1-YL)BENZALDEHYDE is used as a subject of ongoing research to explore its potential uses in various fields, including its interactions with biological targets and its potential applications in the treatment of various conditions.

InChI:InChI=1/C13H18N2O/c1-2-14-7-9-15(10-8-14)13-6-4-3-5-12(13)11-16/h3-6,11H,2,7-10H2,1H3

Upstream product

• 5308-25-8 4-ethylpiperazine 
• 446-52-6 2-Fluorobenzaldehyde 

Relevant articles and documents

Ruthenium catalyzed β-C(sp3)-H functionalization on the 'privileged' piperazine nucleus

β-C(sp3)-H functionalization on the 'privileged' piperazine nucleus has been disclosed using ruthenium catalysis. The ruthenium catalyzed synthesis of a variety of piperazine fused indoles from ortho-piperazinyl (hetero)aryl aldehydes is presented. This transformation takes place via the dehydrogenation of piperazine followed by an intramolecular nucleophilic addition of the transient enamine moiety onto the carbonyl group and aromatization cascade.

Design, synthesis and anticancer activity of functionalized spiro-quinolines with barbituric and thiobarbituric acids

A new series of spiro-quinoline compounds have been accomplished by the reaction of barbituric acid or thiobarbituric acid with derivatives of benzisoxazole-5-carbaldehyde or 2-substituted benzaldehyde. These compounds were evaluated for their in vitro cy

NOVEL BENZYL(IDENE)-LACTAM DERIVATIVES

The present invention relates to novel benzyl(idene)-lactam derivatives, compounds of the formula (I) wherein R1 is a group of the formula G1 or G2 depicted below, wherein R1, R3, R6, R13, X, a, n and m are as defined herein, their pharmaceutically acceptable salts, and pharmaceutical compositions which include selective antagonists, inverse agonists and partial agonists of serotonin 1 (5-HT1) receptors, specifically, of one or both of the 5-HT1A and 5-HT1B receptors. The compounds of the invention are useful in treating or preventing depression, anxiety, obsessive compulsive disorder (OCD) and other disorders for which a 5-HT1 agonist or antagonist is indicated and have reduced potential for cardiac side effects, in particular QTc prolongation.